Qube Research & Technologies (QRT)
KRRO icon

Qube Research & Technologies (QRT)’s Korro Bio KRRO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,750
Closed -$195K – 3749
2024
Q2 		$195K Sell
5,750
-17,461
-75% -$965K ﹤0.01% 2433
2024
Q1 		$2.09M Buy
23,211
+22,206
+2,210% +$1.21M ﹤0.01% 1727
2023
Q4 		$48.2K Buy
+1,005
New +$33.1K ﹤0.01% 3326
2023
Q3 		– Hold
0
– – – 4038
2022
Q4 		– Sell
-499
Closed -$45K – 2761
2022
Q3 		$45K Buy
499
+34
+7% +$3.45K ﹤0.01% 2159
2022
Q2 		$35K Buy
+465
New +$31.4K ﹤0.01% 2186
2020
Q2 		– Sell
-343
Closed -$305K – 1868
2020
Q1 		$305K Buy
+343
New +$370K 0.01% 721

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Qube Research & Technologies (QRT)'s KRRO Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Korro Bio (KRRO) in Q3 2024, closing a stake of 5,750 shares — an estimated $195K sold.

Qube Research & Technologies (QRT) first reported a position in KRRO in Q1 2020 and held it in 6 quarters. The position peaked at $2.09M in Q1 2024. 71 funds tracked by Wall St. Rank hold KRRO as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Korro Bio position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 5,750 Korro Bio shares in Q3 2024, an estimated $195K.
  • Qube Research & Technologies (QRT) first reported a position in Korro Bio in Q1 2020 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s Korro Bio position peaked at $2.09M in Q1 2024.
  • 71 funds tracked by Wall St. Rank held Korro Bio as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.